Sunday, April 19, 2015 2:37:49 PM
Also, regarding my point in the previous post, does it have any merit or would the FDA do the exact same thing it did with mCopax that it did with mEnox if given the opportunity? Would not make sense to me if that were true. Penalizing the innovators seems counter to what the FDA is trying to do and my hope is that the recognition of this will lead to a long run of sole copax approval
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM